These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 24561834

  • 1. [Treatment of pulmonary tuberculosis in a low-prevalence urban area. Compliance and sputum conversion].
    Stoffel C, Lorenz R, Arce M, Rico M, Fernández L, Imaz MS.
    Medicina (B Aires); 2014; 74(1):9-18. PubMed ID: 24561834
    [Abstract] [Full Text] [Related]

  • 2. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
    Tiwari S, Kumar A, Kapoor SK.
    Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
    [Abstract] [Full Text] [Related]

  • 3. Diabetes mellitus and tuberculosis: pattern of tuberculosis, two-month smear conversion and treatment outcomes in Guangzhou, China.
    Mi F, Tan S, Liang L, Harries AD, Hinderaker SG, Lin Y, Yue W, Chen X, Liang B, Gong F, Du J.
    Trop Med Int Health; 2013 Nov; 18(11):1379-85. PubMed ID: 24112411
    [Abstract] [Full Text] [Related]

  • 4. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
    Banu Rekha VV, Balasubramanian R, Swaminathan S, Ramachandran R, Rahman F, Sundaram V, Thyagarajan K, Selvakumar N, Adhilakshmi AR, Iliayas S, Narayanan PR.
    Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750
    [Abstract] [Full Text] [Related]

  • 5. Time to sputum conversion in smear positive pulmonary TB patients on category I DOTS and factors delaying it.
    Parikh R, Nataraj G, Kanade S, Khatri V, Mehta P.
    J Assoc Physicians India; 2012 Aug; 60():22-6. PubMed ID: 23405517
    [Abstract] [Full Text] [Related]

  • 6. Predictors of delayed sputum smear and culture conversion among a Portuguese population with pulmonary tuberculosis.
    Caetano Mota P, Carvalho A, Valente I, Braga R, Duarte R.
    Rev Port Pneumol; 2012 Aug; 18(2):72-9. PubMed ID: 22277838
    [Abstract] [Full Text] [Related]

  • 7. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee.
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [Abstract] [Full Text] [Related]

  • 8. Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TB.
    Chien JY, Chen YT, Shu CC, Lee JJ, Wang JY, Yu CJ, Yang PC.
    Chest; 2013 Jun; 143(6):1725-1732. PubMed ID: 23288018
    [Abstract] [Full Text] [Related]

  • 9. Factors that effect sputum culture conversion rate in hospitalized patients with pulmonary tuberculosis who were applied directly observation therapy and non-directly observation therapy.
    Uzundağ Işeri A, Dulkar G, Selçuk Sönmez O, Yilmaz Aydin L, Yilmaz B.
    Tuberk Toraks; 2010 Jun; 58(1):44-52. PubMed ID: 20517728
    [Abstract] [Full Text] [Related]

  • 10. Profile and treatment outcome of smear-positive TB patients who failed to smear convert after 2 months of treatment in Nigeria.
    Ukwaja KN, Oshi DC, Oshi SN, Alobu I.
    Trans R Soc Trop Med Hyg; 2014 Jul; 108(7):431-8. PubMed ID: 24846911
    [Abstract] [Full Text] [Related]

  • 11. When are follow-up sputum smears actually examined in patients treated for new smear-positive pulmonary tuberculosis?
    Harries AD, Gausi F, Salaniponi FM.
    Int J Tuberc Lung Dis; 2004 Apr; 8(4):440-4. PubMed ID: 15141736
    [Abstract] [Full Text] [Related]

  • 12. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S.
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [Abstract] [Full Text] [Related]

  • 13. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY, Lee LN, Yu CJ, Chien YJ, Yang PC, Tami Group.
    Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
    [Abstract] [Full Text] [Related]

  • 14. Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis.
    Su WJ, Feng JY, Chiu YC, Huang SF, Lee YC.
    Eur Respir J; 2011 Feb; 37(2):376-83. PubMed ID: 20516049
    [Abstract] [Full Text] [Related]

  • 15. Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.
    Mlotshwa M, Abraham N, Beery M, Williams S, Smit S, Uys M, Reddy C, Medina-Marino A.
    BMC Infect Dis; 2016 Aug 02; 16():365. PubMed ID: 27484399
    [Abstract] [Full Text] [Related]

  • 16. Prolonged positivity of sputum smears with negative cultures during treatment for pulmonary tuberculosis.
    van der Kuyp F, Mahan CS.
    Int J Tuberc Lung Dis; 2012 Dec 02; 16(12):1663-7. PubMed ID: 23131266
    [Abstract] [Full Text] [Related]

  • 17. Factors predicting sputum smear conversion and treatment outcomes in new smear-positive pulmonary tuberculosis.
    Unsematham S, Kateruttanakul P.
    J Med Assoc Thai; 2013 Jun 02; 96(6):644-9. PubMed ID: 23951819
    [Abstract] [Full Text] [Related]

  • 18. Decentralisation of treatment for patients with tuberculosis in Malawi: moving from research to policy and practice.
    Salaniponi FM, Gausi F, Mphasa N, Nyirenda TE, Kwanjana JH, Harries AD.
    Int J Tuberc Lung Dis; 2003 Sep 02; 7(9 Suppl 1):S38-47. PubMed ID: 12971653
    [Abstract] [Full Text] [Related]

  • 19. Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion.
    Lee J, Lee BJ, Yoon HI, Lee CT, Lee JH.
    Int J Tuberc Lung Dis; 2012 Oct 02; 16(10):1344-8. PubMed ID: 23107634
    [Abstract] [Full Text] [Related]

  • 20. Success of community-based directly observed anti-tuberculosis treatment in Mongolia.
    Dobler CC, Korver S, Batbayar O, Oyuntsetseg S, Tsolmon B, Wright C, Solongo B, Marais BJ.
    Int J Tuberc Lung Dis; 2015 Jun 02; 19(6):657-62. PubMed ID: 25946355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.